Literature DB >> 27301913

Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.

Veronica Wendy Setiawan1,2, Daniel O Stram1, Jacqueline Porcel2, Shelly C Lu3, Loïc Le Marchand4, Mazen Noureddin3,5.   

Abstract

Chronic liver disease (CLD) and cirrhosis are major sources of morbidity and mortality in the United States. Little is known about the epidemiology of these two diseases in ethnic minority populations in the United States. We examined the prevalence of CLD and cirrhosis by underlying etiologies among African Americans, Native Hawaiians, Japanese Americans, Latinos, and whites in the Multiethnic Cohort. CLD and cirrhosis cases were identified using Medicare claims between 1999 and 2012 among the fee-for-service participants (n = 106,458). We used International Classification of Diseases Ninth Revision codes, body mass index, history of diabetes mellitus, and alcohol consumption from questionnaires to identify underlying etiologies. A total of 5,783 CLD (3,575 CLD without cirrhosis and 2,208 cirrhosis) cases were identified. The prevalence of CLD ranged from 3.9% in African Americans and Native Hawaiians to 4.1% in whites, 6.7% in Latinos, and 6.9% in Japanese. Nonalcoholic fatty liver disease (NAFLD) was the most common cause of CLD in all ethnic groups combined (52%), followed by alcoholic liver disease (21%). NAFLD was the most common cause of cirrhosis in the entire cohort. By ethnicity, NAFLD was the most common cause of cirrhosis in Japanese Americans, Native Hawaiians, and Latinos, accounting for 32% of cases. Alcoholic liver disease was the most common cause of cirrhosis in whites (38.2%), while hepatitis C virus was the most common cause in African Americans (29.8%).
CONCLUSIONS: We showed racial/ethnic variations in the prevalence of CLD and cirrhosis by underlying etiology; NAFLD was the most common cause of CLD and cirrhosis in the entire cohort, and the high prevalence of NAFLD among Japanese Americans and Native Hawaiians is a novel finding, warranting further studies to elucidate the causes. (Hepatology 2016;64:1969-1977).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27301913      PMCID: PMC5115980          DOI: 10.1002/hep.28677

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  48 in total

1.  Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.

Authors:  Lynne E Wagenknecht; Nicholette D Palmer; Donald W Bowden; Jerome I Rotter; Jill M Norris; Julie Ziegler; Yii-Der I Chen; Steven Haffner; Ann Scherzinger; Carl D Langefeld
Journal:  Liver Int       Date:  2011-01-13       Impact factor: 5.828

2.  Linking data from the Multiethnic Cohort Study to Medicare data: linkage results and application to chronic disease research.

Authors:  Veronica Wendy Setiawan; Beth A Virnig; Jacqueline Porcel; Brian E Henderson; Loïc Le Marchand; Lynne R Wilkens; Kristine R Monroe
Journal:  Am J Epidemiol       Date:  2015-04-04       Impact factor: 4.897

3.  Prevalence of fatty liver in a general population of Okinawa, Japan.

Authors:  H Nomura; S Kashiwagi; J Hayashi; W Kajiyama; S Tani; M Goto
Journal:  Jpn J Med       Date:  1988-05

4.  Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.

Authors:  G M McQuillan; P J Coleman; D Kruszon-Moran; L A Moyer; S B Lambert; H S Margolis
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

5.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

6.  Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Authors:  Mazen Noureddin; Katherine P Yates; Ivana A Vaughn; Brent A Neuschwander-Tetri; Arun J Sanyal; Arthur McCullough; Raphael Merriman; Bilal Hameed; Edward Doo; David E Kleiner; Cynthia Behling; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-02       Impact factor: 17.425

7.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

8.  Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT).

Authors:  Scott A Lear; Karin H Humphries; Simi Kohli; Arun Chockalingam; Jiri J Frohlich; C Laird Birmingham
Journal:  Am J Clin Nutr       Date:  2007-08       Impact factor: 7.045

9.  Trends in alcohol consumption patterns among whites, blacks and Hispanics: 1984 and 1995.

Authors:  R Caetano; C L Clark
Journal:  J Stud Alcohol       Date:  1998-11

10.  Racial differences in nonalcoholic fatty liver disease in the U.S. population.

Authors:  Andrea L C Schneider; Mariana Lazo; Elizabeth Selvin; Jeanne M Clark
Journal:  Obesity (Silver Spring)       Date:  2013-06-11       Impact factor: 5.002

View more
  82 in total

1.  Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

Authors:  David Goldberg; Ivo C Ditah; Kia Saeian; Mona Lalehzari; Andrew Aronsohn; Emmanuel C Gorospe; Michael Charlton
Journal:  Gastroenterology       Date:  2017-01-11       Impact factor: 22.682

2.  Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.

Authors:  Robert J Pattison; James Phillip Esteban; Tomoki Sempokuya; Jakrin Kewcharoen; Sumodh Kalathil; Scott K Kuwada
Journal:  Hawaii J Health Soc Welf       Date:  2020-06-01

3.  Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort.

Authors:  Mazen Noureddin; Shira Zelber-Sagi; Lynne R Wilkens; Jacqueline Porcel; Carol J Boushey; Loïc Le Marchand; Hugo R Rosen; Veronica Wendy Setiawan
Journal:  Hepatology       Date:  2020-02-14       Impact factor: 17.425

4.  Current Understanding of Risk for Nonalcoholic Steatohepatitis and Progressive Fibrosis.

Authors:  Mazen Noureddin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-07

5.  Impact of Liver Cirrhosis on Perioperative Outcomes Among Elderly Patients Undergoing Hepatectomy: the Effect of Minimally Invasive Surgery.

Authors:  Kota Sahara; Anghela Z Paredes; Diamantis I Tsilimigras; J Madison Hyer; Katiuscha Merath; Lu Wu; Rittal Mehta; Eliza W Beal; Susan White; Itaru Endo; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-02-04       Impact factor: 3.452

6.  Quality Measures, All-Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis.

Authors:  Marina Serper; David E Kaplan; Justine Shults; Peter P Reese; Lauren A Beste; Tamar H Taddei; Rachel M Werner
Journal:  Hepatology       Date:  2019-06-26       Impact factor: 17.425

7.  The Impact of Cirrhosis on Pancreatic Cancer Surgery: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios Schizas; Spyridon Peppas; Stefanos Giannopoulos; Vasiliki Lagopoulou; Konstantinos S Mylonas; Spyridon Giannopoulos; Dimitrios Moris; Evangelos Felekouras; Konstantinos Toutouzas
Journal:  World J Surg       Date:  2020-10-18       Impact factor: 3.352

Review 8.  Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ma Ai Thanda Han; Rola Saouaf; Walid Ayoub; Tsuyoshi Todo; Edward Mena; Mazen Noureddin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-03-09       Impact factor: 5.045

9.  Premature mortality projections in the USA through 2030: a modelling study.

Authors:  Ana F Best; Emily A Haozous; Amy Berrington de Gonzalez; Pavel Chernyavskiy; Neal D Freedman; Patricia Hartge; David Thomas; Philip S Rosenberg; Meredith S Shiels
Journal:  Lancet Public Health       Date:  2018-07-21

10.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.